首页|人乳头瘤病毒DNA、E6/E7 mRNA及液基薄层细胞学检查对女性宫颈癌的筛查价值

人乳头瘤病毒DNA、E6/E7 mRNA及液基薄层细胞学检查对女性宫颈癌的筛查价值

Screening value of human papilloma virus DNA,E6/E7 mRNA,and thin-prep cytology test for female cervical cancer

扫码查看
目的 探讨人乳头瘤病毒(HPV)DNA、E6/E7 mRNA及液基薄层细胞学检查(TCT)对女性宫颈癌的筛查价值.方法 选取28 021例体检女性,均接受HPV DNA、E6/E7 mRNA和TCT单项或多项检测,记录HPV DNA、E6/E7 mRNA、TCT单独及联合检测对宫颈癌的检出情况.以组织活检结果为金标准,评估HPV DNA、E6/E7 mRNA、TCT单独或联合检测对宫颈癌的筛查价值.结果 TCT、HPV DNA、E6/E7 mRNA对宫颈癌的检出率分别为8.8%、26.9%、29.7%.各方法单独检测时,TCT单独检测筛查宫颈癌的特异度最高(85.53%),但灵敏度最低(28.44%),HPV DNA单独检测筛查宫颈癌的灵敏度最高(60.25%).两种方法联合检测时,HPV DNA+E6/E7 mRNA联合检测筛查宫颈癌的灵敏度最高(81.75%),特异度最低(26.34%),TCT+HPV DNA联合检测筛查宫颈癌的特异度(61.08%)和阴性预测值(57.11%)最高,任意两种方法联合检测筛查宫颈癌的灵敏度、特异度比较,差异均有统计学意义(P﹤0.05).TCT+HPV DNA+E6/E7 mRNA联合检测筛查宫颈癌的灵敏度、特异度与HPV DNA+E6/E7 mRNA检测比较,差异均无统计学意义(P﹥0.05),但灵敏度高于TCT+E6/E7 mRNA联合检测,特异度低于TCT+E6/E7 mRNA联合检测,差异均有统计学意义(P﹤0.05).结论 HPV DNA检测适合作为女性健康体检者宫颈癌筛查的首选方法,E6/E7 mRNA与TCT检测可作为宫颈癌进一步检查的优选.HPV DNA+E6/E7 mRNA联合检测具有较高的灵敏度和阳性预测值,可作为年轻女性宫颈癌筛查的优选方案,联合检测对提高阳性率及降低假阳性率有帮助.
Objective To investigate the screening value of human papilloma virus(HPV)DNA,E6/E7 mRNA,and thin-prep cytology test(TCT)for female cervical cancer.Method A total of 28 021 women who underwent physical ex-amination were selected,and all subjects received single or multiple tests for HPV DNA,E6/E7 mRNA,and TCT detec-tion.The detection rate of cervical cancer by HPV DNA,E6/E7 mRNA,and TCT single or combined detection were re-corded.The tissue biopsy results as the gold standard,the screening value of HPV DNA,E6/E7 mRNA,and TCT single or combined detection for cervical cancer were evaluated.Result The detection rates of TCT,HPV DNA,E6/E7 mRNA for cervical cancer were 8.8%,26.9%,and 29.7%,respectively.When each method single detection,the specificity(85.53%)for screening cervical cancer of TCT single detection was the highest,but the sensitivity(28.44%)was the low-est,the sensitivity(60.25%)for screening cervical cancer of HPV DNA single detection was the highest.When any two methods combined detection,the sensitivity(81.75%)for screening cervical cancer of HPV DNA+E6/E7 mRNA com-bined detection was the highest,the specificity(61.08%)and negative predictive value(57.11%)for screening cervical cancer of TCT+HPV DNA combined detection were the highest.The sensitivity and specificity of any two methods com-bined detection for screening cervical cancer were compared,the differences were statistically significant(P<0.05).The sensitivity and specificity of TCT+HPV DNA+E6/E7 mRNA and HPV DNA+E6/E7 mRNA combined detection for screening cervical cancer were not significantly differences(P>0.05),but the sensitivity of TCT+HPV DNA+E6/E7 mRNA was higher than that of TCT+E6/E7mRNA combined detection,the specificity was lower than that of TCT+E6/E7 mRNA combined detection,and the differences were statistically significant(P<0.05).Conclusion HPV DNA testing is suitable as the preferred method for cervical cancer screening in female health checkups,while E6/E7 mRNA and TCT testing can be preferred for further examination of cervical cancer.The combined detection of HPV DNA+E6/E7 mRNA has high sensitivity and positive predictive value,and can be used as the preferred screening method for cervical cancer in young women.The combined detection is helpful in improving the positive rate and reducing false positive rate.

human papilloma virus DNAE6/E7 mRNAthin-prep cytology testcervical cancerhuman papilloma virus

刘德美、董晓彤、柳林、李秀凤、王慧、陈国华、张云香

展开 >

潍坊市人民医院 精准病理诊断中心,山东 潍坊 2610410

潍坊市人民医院 妇科,山东 潍坊 2610410

潍坊市人民医院 健康管理中心,山东 潍坊 2610410

人乳头瘤病毒DNA E6/E7 mRNA 液基薄层细胞学检查 宫颈癌 人乳头瘤病毒

山东省医药卫生科技发展计划项目

2017WS807

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(13)